ArticleBlood cancer journal2013

A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor.

Y Hattori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.